Abstract
The imperative for pharmacists to play a more significant role in working with patients affected by cognitive impairment has never been greater. This is a rapidly evolving issue, and data from the organization Alzheimer's Disease International presents a range of epidemiological facts that should be of concern to health practitioners, health administrators, governments and other funders, policy makers, and the wider public. Consumers have every right to expect, and indeed to demand, action from agencies that can and should act. According to Alzheimer's Disease International, the number of cases of dementia worldwide is expected to increase by 100% over the coming 20 years.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
